Skip to main content
Article thumbnail
Location of Repository

A randomised, 52-week, treat-to-target trial comparing insulin determin with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

By Melanie J. Davies


This is the author's final draft version of the item published as Diabetologia, 51 (3), pp. 408-41

Publisher: Springer Verlag
Year: 2008
OAI identifier:

Suggested articles

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.